WCLC 2025 - Posters & ePosters-EP.08.51 Impact of KRAS Mutations on Outcomes in Stage III Non-Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab

EP.08.51 Impact of KRAS Mutations on Outcomes in Stage III Non-Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab

Asset Subtitle

Nikhil Mankuzhy

Meta Tag

Speaker Nikhil Mankuzhy

Topic Local-Regional Non-small Cell Lung Cancer